WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is showcasing its latest innovations in cancer research at the AACR Annual Meeting 2026, to be held in San Diego, April 17-22. The Company’s comprehensive suite of research use only (RUO) oncology solutions are designed to elevate preclinical and translational research workflows, helping scientists accelerate discoveries that drive the future of cancer science. The full scope of Revvity’s integrated oncology solutions and reagents that will be on d
2026 Copyright © News-Matic.com. All Rights Reserved
